Skip to main content
Premium Trial:

Request an Annual Quote

Biofidelity: Lee Newcomer

Biofidelity has added Lee Newcomer to its scientific advisory board. Newcomer is an oncologist who joins the rest of the board in helping guide the development and launch of Biofidelity's Aspyre technology, an enzymatic diagnostic method for identifying DNA mismatches. 

Newcomer previously served as senior vice president for oncology and genetics at United Healthcare and as CMO and senior vice president of health policy and strategy at UnitedHealth Group. Newcomer practiced medical oncology for nine years prior to working with UnitedHealth Group and is a former chairman of Park Nicollet Health Services.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.